Consequences of OM
Oral mucositis (OM) is reported as one of the worst side effects of cancer
treatment.1 Its effects can produce
consequences such as the following:
- Treatment delays
- Additional hospitalizations and procedures
- Infections
- Additional medical costs2
In addition, OM can affect your quality of life during treatment by making
it harder for you to eat, drink and communicate. This can frustrate your efforts
to cope with your disease.3 In some cases,
people with severe OM may even require intravenous (I.V.) nutritional therapy,
a feeding tube, or both.2
Because sores provide a doorway into your body for the microbes that normally
live in your mouth, OM greatly increases your risk of infection at a time when
your body is not well prepared to fight it.3 This
can lead to hospitalization, and in some cases, infections can be life-threatening.3,2
Treatment costs also rise as a result of OM. In one study, a researcher estimated
treatment costs for study participants:
- For participants without OM, the average cost of hospitalization per cycle would have
been about $3,893.
- For participants with OM, the average cost of hospitalization per cycle would
have been nearly twice that amount, at about $6,277.4
Visit Preventing Oral Mucositis to learn how you may be able to avoid
these consequences, and visit Managing Oral Mucositis to learn how you
can better manage OM if you develop it.
References
- Rubenstein, EB, et al., Clinical practice guidelines for the prevention
and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004;
100(9 Suppl):2026-46.
- Sonis, ST, et al., Perspectives on cancer therapy-induced mucosal injury:
pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;
100(9 Suppl):1995-2025.
- Brown, CG,Wingard, J Clinical consequences of oral mucositis. Semin
Oncol Nurs 2004; 20(1):16-21.
- Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein
EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced
mucositis. Cancer 2003; 98:1531-9.